Caldwell Sutter Capital, Inc. Bristol Myers Squibb CO Transaction History
Caldwell Sutter Capital, Inc.
- $234 Billion
- Q3 2025
A detailed history of Caldwell Sutter Capital, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 6,028 shares of BMY stock, worth $282,170. This represents 0.12% of its overall portfolio holdings.
Number of Shares
6,028
Previous 5,405
11.53%
Holding current value
$282,170
Previous $250 Million
8.66%
% of portfolio
0.12%
Previous 0.11%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,679Shares Held
1.58BCall Options Held
28.2MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...